Stem definition | Drug id | CAS RN |
---|---|---|
ergot alkaloid derivatives | 4420 | 25447-66-9 |
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | N04BC03 | NERVOUS SYSTEM ANTI-PARKINSON DRUGS DOPAMINERGIC AGENTS Dopamine agonists |
MeSH PA | D002317 | Cardiovascular Agents |
MeSH PA | D015259 | Dopamine Agents |
MeSH PA | D018491 | Dopamine Agonists |
MeSH PA | D018377 | Neurotransmitter Agents |
MeSH PA | D014665 | Vasodilator Agents |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 12.57 | acidic |
pKa2 | 13.18 | acidic |
pKa3 | 13.67 | acidic |
pKa4 | 7.56 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 2B | GPCR | AGONIST | Ki | 7.48 | IUPHAR | ||||
5-hydroxytryptamine receptor 7 | GPCR | ANTAGONIST | Ki | 6.50 | IUPHAR | ||||
5-hydroxytryptamine receptor 7 | GPCR | ANTAGONIST | Ki | 7 | IUPHAR |
ID | Source |
---|---|
D07835 | KEGG_DRUG |
14271-05-7 | SECONDARY_CAS_RN |
4017832 | VANDF |
4020124 | VANDF |
C0012290 | UMLSCUI |
CHEMBL1743263 | ChEMBL_ID |
CHEMBL3707289 | ChEMBL_ID |
DB13385 | DRUGBANK_ID |
282 | IUPHAR_LIGAND_ID |
67V3FSL2GL | UNII |
114948 | PUBCHEM_CID |
1426902 | RXNORM |
005801 | NDDF |
005802 | NDDF |
24650007 | SNOMEDCT_US |
412173004 | SNOMEDCT_US |
426582003 | SNOMEDCT_US |
708572008 | SNOMEDCT_US |
D025443 | MESH_DESCRIPTOR_UI |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Ergoloid Mesylates | HUMAN PRESCRIPTION DRUG LABEL | 4 | 53489-281 | TABLET | 0.22 mg | ORAL | ANDA | 11 sections |
Ergoloid Mesylates | HUMAN PRESCRIPTION DRUG LABEL | 4 | 68151-2780 | TABLET | 0.22 mg | ORAL | ANDA | 10 sections |